PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 0.52 ▲ 0.02 (3.64%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genprex Inc | GNPX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.498828 | 0.52 | 0.471 | 0.50 | 0.498828 | 19:57:44 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.512 | 0.52 | 0.008 | 1.54% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 440 | 230,234 | $ 0.4937165 | $ 113,670 | 66,826 | 0.43 - 2.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:50:47 | 1 | $ 0.512 | USD |
Genprex Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 7.90M | 15.84M | $ -12.37M | -0.89 | - | 15.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 4.10% |
Genprex News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/09/2019 | 08:00 | Business Wire | Genprex to Present at the MicroCap Rodeo Investor Conference |
| 10/07/2019 | 08:00 | Business Wire | Genprex’s Pioneering Use of Non-Viral Delivery for Gene.. |
| 10/04/2019 | 16:00 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) |
| 9/26/2019 | 08:30 | GlobeNewswire Inc. | Genprex (GNPX) Featured in Audio Publication Discussing New.. |
| 9/25/2019 | 08:30 | GlobeNewswire Inc. | Genprex (GNPX) Featured in Publication on Advances in.. |
| 9/24/2019 | 08:45 | NetworkNewsWire | Gene Therapies with Potential to Conquer Tough-to-Tackle.. |
| 9/18/2019 | 08:00 | Business Wire | Genprex to Present Via Webcast at the Singular Research.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNPX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7 | 0.756 | 0.43 | 0.5159 | 128k | -0.201172 | -28.74% |
| 1 Month | 0.95 | 0.95 | 0.43 | 0.6182 | 53k | -0.451172 | -47.49% |
| 3 Months | 1.12 | 1.21 | 0.43 | 0.8178 | 50k | -0.621172 | -55.46% |
| 6 Months | 1.8 | 1.9 | 0.43 | 1.0466 | 41k | -1.301172 | -72.29% |
| 1 Year | 1.92 | 2.49 | 0.43 | 1.3665 | 43k | -1.421172 | -74.02% |
| 3 Years | 4.69 | 19.4499 | 0.43 | 7.6917 | 91k | -4.191172 | -89.36% |
| 5 Years | 4.69 | 19.4499 | 0.43 | 7.6917 | 91k | -4.191172 | -89.36% |
Genprex Description
| Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against cancer cells. |
